Study for treatment of castration resistant metastatic prostate cancer
Primary disease category: Cancer
Secondary disease categories: Prostate Cancer
Sponsor: SWOG
Protocol number: A031201
Projected enrollment dates: June 2014 to December 2019
Official study title: Phase III Trial of Enzalutamide Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
External link(s):
UA Cancer Center Website
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/NCT01949337